Relapsing polychondritis. Survival and predictive role of early disease manifestations
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Relapsing polychondritis survival is 74% at 5 years, with infection and vasculitis as leading causes of death. Early anemia and specific symptoms predict outcomes in this rare autoimmune disease.
Area Of Science
- Rheumatology
- Immunology
- Internal Medicine
Background
- Relapsing polychondritis (RP) is a rare, progressive autoimmune disorder affecting cartilage.
- Understanding the natural history and prognostic factors of RP is crucial for patient management.
Purpose Of The Study
- To define the natural history of relapsing polychondritis.
- To determine survival probabilities and causes of death in RP patients.
- To identify early clinical manifestations predicting mortality.
Main Methods
- Retrospective analysis of 112 patients diagnosed with relapsing polychondritis at a single institution.
- Covariate analysis was employed to identify predictors of mortality.
- Survival probabilities were calculated at 5 and 10 years post-diagnosis.
Main Results
- The 5- and 10-year survival rates after diagnosis were 74% and 55%, respectively.
- Infection, systemic vasculitis, and malignancy were the primary causes of death.
- Anemia at diagnosis was a significant predictor of decreased survival across all patients.
- For patients under 51, saddle-nose deformity and systemic vasculitis were poor prognostic signs; for older patients, only anemia predicted outcome.
- Airway chondritis accounted for only 10% of deaths; corticosteroid use did not impact survival.
Conclusions
- Relapsing polychondritis has a significant impact on long-term survival, with infection and systemic vasculitis being major threats.
- Early identification of anemia and specific clinical features in younger patients can aid in predicting prognosis.
- While airway involvement is a concern, it is not the leading cause of mortality in this cohort.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

